CCL22 and cancer: The efficient uptake of MP by M2 macrophages accompanied by increase production of CCL22 and CD209, which recruit regulatory T cells and dendritic cells into cancer tissue (39, 40), enhanced the M2 immune activity and can be used to target macrophages involved in cancer progression.